DSP is a cell–cell adhesion molecule reported to have an AT activity in non-small-cell lung cancer (NSLC) by inhibition of the Wnt/β-catenin signaling pathway, followed by inhibition of cell proliferation, migration, and invasion and an increase in sensitivity to induced apoptosis [40]. Here, DSP is linked to non-small cell lung carcinoma.